跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22 条关于
“Dianthus”
全部
22
临床试验
3
药物
4
机构
2
资讯
13
12天前
Dianthus Maintains Hold Rating as Competitor C1s Faces CIDP Setback While Claseprubart Advances
去年
Dianthus Therapeutics Soars 50% Following Positive Phase 2 Results for Myasthenia Gravis Drug
去年
Dianthus Therapeutics Closes Upsized $288 Million Public Offering to Advance Complement Therapeutics Pipeline
11个月前
Dianthus Therapeutics Secures Exclusive License for DNTH212, a Dual-Target Autoimmune Therapy
去年
Dianthus Therapeutics' Claseprubart Meets All Endpoints in Phase 2 Myasthenia Gravis Trial
6个月前
Dianthus Therapeutics Announces Interim Results from Phase 3 CAPTIVATE Trial of Claseprubart for CIDP
10个月前
NanoTemper Acquires Envue Technologies and Launches Dianthus α to Advance Single-Molecule Drug Discovery
去年
Dianthus Therapeutics Completes Enrollment in Phase 2 MaGic Trial for Generalized Myasthenia Gravis Treatment
8个月前
Leads Biolabs and Dianthus Therapeutics Initiate Phase 1 Trial of Novel Bifunctional Autoimmune Therapy LBL-047
去年
Hesperos' Human-on-a-Chip Technology Supports Phase II Trial of DNTH103 for Generalized Myasthenia Gravis
第 1 页,共 2 页
上一页
下一页